Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
1.700
0.00 (0.00%)
At close: Mar 3, 2026
Helix BioMedix Market Cap
Helix BioMedix has a market cap or net worth of $382.01 thousand as of March 5, 2026. Its market cap has decreased by -97.52% in one year.
Market Cap
382.01K
Enterprise Value
n/a
Revenue
2.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.70
Market Cap Chart
Since July 26, 1995, Helix BioMedix's market cap has decreased from 1.59M to 382.01K, a decrease of -76.05%. That is a compound annual growth rate of -4.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 382.01K | -15.00% |
| Dec 31, 2025 | 449.42K | -75.00% |
| Dec 26, 2024 | 1.80M | -76.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scorpius Holdings | 611.43K |
| Bio-Path Holdings | 592.29K |
| Altamira Therapeutics | 571.55K |
| Windtree Therapeutics | 565.62K |
| Aibotics | 538.09K |
| Hepion Pharmaceuticals | 424.72K |
| Regenerative Medical Technology Group | 394.17K |
| Actavia Life Sciences | 385.91K |